Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

Also called NCT02848781

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 180 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02848781
Other papers using this trial's data
  • First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial Circulation, 2022-06-21 DOI, PubMed 35507499

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, China, Japan, South Korea, Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02848781. Randomized; no masking; primary purpose treatment. Start 2015-11-30 (actual); primary completion 2021-03-29 (actual). Results posted on 2022-12-14.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial
Acronym
PAUSE-SCD
Condition
Ventricular Tachycardia (VT)
Intervention (Device)
Implantable Cardioverter Defibrillator (ICD)
Intervention (Procedure)
Catheter Ablation
Lead sponsor
University of Arizona (class: other)

Record details

Record id
cardio:ct-nct02848781
Content hash
6c0230a3398c451ffd1713db174a14024b43bd3518812f186098bffaa2fd5175